Cargando…
P23 EMAGINE/CARTITUDE-6: A RANDOMIZED PHASE 3 STUDY OF DVRD FOLLOWED BY CILTACABTAGENE AUTOLEUCEL VERSUS DVRD FOLLOWED BY AUTOLOGOUS STEM CELL TRANSPLANT IN TRANSPLANT-ELIGIBLE PATIENTS WITH NEWLY DIAGNOSED MULTIPLE MYELOMA
| Autores principales: | , , , , , , , , , , , , , , , , , , , , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Lippincott Williams & Wilkins
2023
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10171573/ http://dx.doi.org/10.1097/01.HS9.0000936220.68605.8b |
| _version_ | 1785039448082219008 |
|---|---|
| author | Broijl, A. San-Miguel, J. Suzuki, K. Krishnan, A. van de Donk, N. Cook, G. Jakubowiak, A. Madduri, D. Afifi, S. Stevens, A. Schecter, J. Deraedt, W. Kuppens, S. Mistry, P. Pacaud, L. Boccadoro, M. Gay, F. Mina, R. Rasche, L. Moreau, P. Mateos, M. Einsele, H. Sonneveld, P. |
| author_facet | Broijl, A. San-Miguel, J. Suzuki, K. Krishnan, A. van de Donk, N. Cook, G. Jakubowiak, A. Madduri, D. Afifi, S. Stevens, A. Schecter, J. Deraedt, W. Kuppens, S. Mistry, P. Pacaud, L. Boccadoro, M. Gay, F. Mina, R. Rasche, L. Moreau, P. Mateos, M. Einsele, H. Sonneveld, P. |
| author_sort | Broijl, A. |
| collection | PubMed |
| description | |
| format | Online Article Text |
| id | pubmed-10171573 |
| institution | National Center for Biotechnology Information |
| language | English |
| publishDate | 2023 |
| publisher | Lippincott Williams & Wilkins |
| record_format | MEDLINE/PubMed |
| spelling | pubmed-101715732023-05-11 P23 EMAGINE/CARTITUDE-6: A RANDOMIZED PHASE 3 STUDY OF DVRD FOLLOWED BY CILTACABTAGENE AUTOLEUCEL VERSUS DVRD FOLLOWED BY AUTOLOGOUS STEM CELL TRANSPLANT IN TRANSPLANT-ELIGIBLE PATIENTS WITH NEWLY DIAGNOSED MULTIPLE MYELOMA Broijl, A. San-Miguel, J. Suzuki, K. Krishnan, A. van de Donk, N. Cook, G. Jakubowiak, A. Madduri, D. Afifi, S. Stevens, A. Schecter, J. Deraedt, W. Kuppens, S. Mistry, P. Pacaud, L. Boccadoro, M. Gay, F. Mina, R. Rasche, L. Moreau, P. Mateos, M. Einsele, H. Sonneveld, P. Hemasphere Poster Lippincott Williams & Wilkins 2023-05-09 /pmc/articles/PMC10171573/ http://dx.doi.org/10.1097/01.HS9.0000936220.68605.8b Text en Copyright © 2023 the Author(s). Published by Wolters Kluwer Health, Inc. on behalf of the European Hematology Association. https://creativecommons.org/licenses/by-nc-nd/4.0/This is an open access Abstract Book distributed under the Attribution-NonCommercial-NoDerivs (CC BY-NC-ND) (https://creativecommons.org/licenses/by-nc-nd/4.0/) which allows third parties to download the articles and share them with others as long as they credit the author and the Abstract Book, but they cannot change the content in any way or use them commercially. |
| spellingShingle | Poster Broijl, A. San-Miguel, J. Suzuki, K. Krishnan, A. van de Donk, N. Cook, G. Jakubowiak, A. Madduri, D. Afifi, S. Stevens, A. Schecter, J. Deraedt, W. Kuppens, S. Mistry, P. Pacaud, L. Boccadoro, M. Gay, F. Mina, R. Rasche, L. Moreau, P. Mateos, M. Einsele, H. Sonneveld, P. P23 EMAGINE/CARTITUDE-6: A RANDOMIZED PHASE 3 STUDY OF DVRD FOLLOWED BY CILTACABTAGENE AUTOLEUCEL VERSUS DVRD FOLLOWED BY AUTOLOGOUS STEM CELL TRANSPLANT IN TRANSPLANT-ELIGIBLE PATIENTS WITH NEWLY DIAGNOSED MULTIPLE MYELOMA |
| title | P23 EMAGINE/CARTITUDE-6: A RANDOMIZED PHASE 3 STUDY OF DVRD FOLLOWED BY CILTACABTAGENE AUTOLEUCEL VERSUS DVRD FOLLOWED BY AUTOLOGOUS STEM CELL TRANSPLANT IN TRANSPLANT-ELIGIBLE PATIENTS WITH NEWLY DIAGNOSED MULTIPLE MYELOMA |
| title_full | P23 EMAGINE/CARTITUDE-6: A RANDOMIZED PHASE 3 STUDY OF DVRD FOLLOWED BY CILTACABTAGENE AUTOLEUCEL VERSUS DVRD FOLLOWED BY AUTOLOGOUS STEM CELL TRANSPLANT IN TRANSPLANT-ELIGIBLE PATIENTS WITH NEWLY DIAGNOSED MULTIPLE MYELOMA |
| title_fullStr | P23 EMAGINE/CARTITUDE-6: A RANDOMIZED PHASE 3 STUDY OF DVRD FOLLOWED BY CILTACABTAGENE AUTOLEUCEL VERSUS DVRD FOLLOWED BY AUTOLOGOUS STEM CELL TRANSPLANT IN TRANSPLANT-ELIGIBLE PATIENTS WITH NEWLY DIAGNOSED MULTIPLE MYELOMA |
| title_full_unstemmed | P23 EMAGINE/CARTITUDE-6: A RANDOMIZED PHASE 3 STUDY OF DVRD FOLLOWED BY CILTACABTAGENE AUTOLEUCEL VERSUS DVRD FOLLOWED BY AUTOLOGOUS STEM CELL TRANSPLANT IN TRANSPLANT-ELIGIBLE PATIENTS WITH NEWLY DIAGNOSED MULTIPLE MYELOMA |
| title_short | P23 EMAGINE/CARTITUDE-6: A RANDOMIZED PHASE 3 STUDY OF DVRD FOLLOWED BY CILTACABTAGENE AUTOLEUCEL VERSUS DVRD FOLLOWED BY AUTOLOGOUS STEM CELL TRANSPLANT IN TRANSPLANT-ELIGIBLE PATIENTS WITH NEWLY DIAGNOSED MULTIPLE MYELOMA |
| title_sort | p23 emagine/cartitude-6: a randomized phase 3 study of dvrd followed by ciltacabtagene autoleucel versus dvrd followed by autologous stem cell transplant in transplant-eligible patients with newly diagnosed multiple myeloma |
| topic | Poster |
| url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10171573/ http://dx.doi.org/10.1097/01.HS9.0000936220.68605.8b |
| work_keys_str_mv | AT broijla p23emaginecartitude6arandomizedphase3studyofdvrdfollowedbyciltacabtageneautoleucelversusdvrdfollowedbyautologousstemcelltransplantintransplanteligiblepatientswithnewlydiagnosedmultiplemyeloma AT sanmiguelj p23emaginecartitude6arandomizedphase3studyofdvrdfollowedbyciltacabtageneautoleucelversusdvrdfollowedbyautologousstemcelltransplantintransplanteligiblepatientswithnewlydiagnosedmultiplemyeloma AT suzukik p23emaginecartitude6arandomizedphase3studyofdvrdfollowedbyciltacabtageneautoleucelversusdvrdfollowedbyautologousstemcelltransplantintransplanteligiblepatientswithnewlydiagnosedmultiplemyeloma AT krishnana p23emaginecartitude6arandomizedphase3studyofdvrdfollowedbyciltacabtageneautoleucelversusdvrdfollowedbyautologousstemcelltransplantintransplanteligiblepatientswithnewlydiagnosedmultiplemyeloma AT vandedonkn p23emaginecartitude6arandomizedphase3studyofdvrdfollowedbyciltacabtageneautoleucelversusdvrdfollowedbyautologousstemcelltransplantintransplanteligiblepatientswithnewlydiagnosedmultiplemyeloma AT cookg p23emaginecartitude6arandomizedphase3studyofdvrdfollowedbyciltacabtageneautoleucelversusdvrdfollowedbyautologousstemcelltransplantintransplanteligiblepatientswithnewlydiagnosedmultiplemyeloma AT jakubowiaka p23emaginecartitude6arandomizedphase3studyofdvrdfollowedbyciltacabtageneautoleucelversusdvrdfollowedbyautologousstemcelltransplantintransplanteligiblepatientswithnewlydiagnosedmultiplemyeloma AT maddurid p23emaginecartitude6arandomizedphase3studyofdvrdfollowedbyciltacabtageneautoleucelversusdvrdfollowedbyautologousstemcelltransplantintransplanteligiblepatientswithnewlydiagnosedmultiplemyeloma AT afifis p23emaginecartitude6arandomizedphase3studyofdvrdfollowedbyciltacabtageneautoleucelversusdvrdfollowedbyautologousstemcelltransplantintransplanteligiblepatientswithnewlydiagnosedmultiplemyeloma AT stevensa p23emaginecartitude6arandomizedphase3studyofdvrdfollowedbyciltacabtageneautoleucelversusdvrdfollowedbyautologousstemcelltransplantintransplanteligiblepatientswithnewlydiagnosedmultiplemyeloma AT schecterj p23emaginecartitude6arandomizedphase3studyofdvrdfollowedbyciltacabtageneautoleucelversusdvrdfollowedbyautologousstemcelltransplantintransplanteligiblepatientswithnewlydiagnosedmultiplemyeloma AT deraedtw p23emaginecartitude6arandomizedphase3studyofdvrdfollowedbyciltacabtageneautoleucelversusdvrdfollowedbyautologousstemcelltransplantintransplanteligiblepatientswithnewlydiagnosedmultiplemyeloma AT kuppenss p23emaginecartitude6arandomizedphase3studyofdvrdfollowedbyciltacabtageneautoleucelversusdvrdfollowedbyautologousstemcelltransplantintransplanteligiblepatientswithnewlydiagnosedmultiplemyeloma AT mistryp p23emaginecartitude6arandomizedphase3studyofdvrdfollowedbyciltacabtageneautoleucelversusdvrdfollowedbyautologousstemcelltransplantintransplanteligiblepatientswithnewlydiagnosedmultiplemyeloma AT pacaudl p23emaginecartitude6arandomizedphase3studyofdvrdfollowedbyciltacabtageneautoleucelversusdvrdfollowedbyautologousstemcelltransplantintransplanteligiblepatientswithnewlydiagnosedmultiplemyeloma AT boccadorom p23emaginecartitude6arandomizedphase3studyofdvrdfollowedbyciltacabtageneautoleucelversusdvrdfollowedbyautologousstemcelltransplantintransplanteligiblepatientswithnewlydiagnosedmultiplemyeloma AT gayf p23emaginecartitude6arandomizedphase3studyofdvrdfollowedbyciltacabtageneautoleucelversusdvrdfollowedbyautologousstemcelltransplantintransplanteligiblepatientswithnewlydiagnosedmultiplemyeloma AT minar p23emaginecartitude6arandomizedphase3studyofdvrdfollowedbyciltacabtageneautoleucelversusdvrdfollowedbyautologousstemcelltransplantintransplanteligiblepatientswithnewlydiagnosedmultiplemyeloma AT raschel p23emaginecartitude6arandomizedphase3studyofdvrdfollowedbyciltacabtageneautoleucelversusdvrdfollowedbyautologousstemcelltransplantintransplanteligiblepatientswithnewlydiagnosedmultiplemyeloma AT moreaup p23emaginecartitude6arandomizedphase3studyofdvrdfollowedbyciltacabtageneautoleucelversusdvrdfollowedbyautologousstemcelltransplantintransplanteligiblepatientswithnewlydiagnosedmultiplemyeloma AT mateosm p23emaginecartitude6arandomizedphase3studyofdvrdfollowedbyciltacabtageneautoleucelversusdvrdfollowedbyautologousstemcelltransplantintransplanteligiblepatientswithnewlydiagnosedmultiplemyeloma AT einseleh p23emaginecartitude6arandomizedphase3studyofdvrdfollowedbyciltacabtageneautoleucelversusdvrdfollowedbyautologousstemcelltransplantintransplanteligiblepatientswithnewlydiagnosedmultiplemyeloma AT sonneveldp p23emaginecartitude6arandomizedphase3studyofdvrdfollowedbyciltacabtageneautoleucelversusdvrdfollowedbyautologousstemcelltransplantintransplanteligiblepatientswithnewlydiagnosedmultiplemyeloma |